BONESUPPORT: Initial take on Q4 2022 results - Redeye
Redeye provides an initial take on BONESUPPORT’s Q4 results, and we are encouraged by the company beating our sales estimates. We will return shortly with a more in-depth take on the report and fair value range changes.
ANNONS
Redeye provides an initial take on BONESUPPORT’s Q4 results, and we are encouraged by the company beating our sales estimates. We will return shortly with a more in-depth take on the report and fair value range changes.